News Scotland says yes to Truvada as PrEP The Scottish Medicines Consortium has approved the use of Gilead’s Truvada for use in preventing new HIV infections, so called pre-exposure prophylaxis (PrEP).
News NHS England confirms HIV prevention funding - but only via c... Large trial of HIV PrEP could lead to national programme
News Gilead donates Truvada to HIV trial patients PROUD trial patients can continue treatment for six months.
News EU approves Gilead's Truvada for HIV prevention But there are funding problems in UK, Australia and Canada.
R&D LSX2026: On a therapeutic vision for ocular disease, with Al... Alexander Gebauer, co-founder & executive chairman of Galimedix Therapeutics, discusses transforming treatment of major neurodegenerative eye diseases
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
